Date published: 2026-5-16

1-800-457-3801

SCBT Portrait Logo
Seach Input

RPA 34 kDa subunit Inhibitors

RPA 34 kDa subunit inhibitors belong to a specialized class of chemical compounds that target the Replication Protein A (RPA) complex by specifically inhibiting the 34 kDa subunit. The RPA complex is a critical component of DNA metabolism and repair processes within cells, playing an essential role in DNA replication, recombination, and repair. The 34 kDa subunit of RPA is particularly significant because it is involved in the stabilization of single-stranded DNA (ssDNA) regions during these cellular processes. By binding to ssDNA and preventing it from forming secondary structures or undergoing degradation, RPA 34 kDa subunit ensures the fidelity of DNA replication and facilitates DNA damage detection and repair. Inhibitors targeting this specific subunit can disrupt these vital functions, thereby impacting various cellular processes.

Structurally, RPA 34 kDa subunit inhibitors are designed to interact with the 34 kDa subunit of the RPA complex, interfering with its ability to bind to ssDNA. This interference can lead to the destabilization of DNA replication intermediates, hinder the recognition of damaged DNA sites, and disrupt the overall DNA repair machinery. Researchers have been exploring these inhibitors as valuable tools for studying the molecular mechanisms of DNA metabolism and repair, offering insights into fundamental cellular processes. Understanding the biochemical and structural basis of these inhibitors' interactions with the RPA 34 kDa subunit can shed light on the intricacies of DNA maintenance in cells and may inform the development of novel strategies for manipulating DNA repair pathways in various biological contexts.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Camptothecin

7689-03-4sc-200871
sc-200871A
sc-200871B
50 mg
250 mg
100 mg
$58.00
$186.00
$94.00
21
(2)

Camptothecin stabilizes the DNA-topoisomerase I complex, leading to DNA breaks. This may challenge the DNA replication machinery and influence RPA2 function or stability.

Hydroxyurea

127-07-1sc-29061
sc-29061A
5 g
25 g
$78.00
$260.00
18
(1)

By inhibiting ribonucleotide reductase and thus affecting DNA synthesis, Hydroxyurea could indirectly modulate RPA2 function.

Aphidicolin

38966-21-1sc-201535
sc-201535A
sc-201535B
1 mg
5 mg
25 mg
$84.00
$306.00
$1104.00
30
(3)

This compound inhibits DNA polymerase α, potentially leading to replication stress and altered RPA2 dynamics.

Etoposide (VP-16)

33419-42-0sc-3512B
sc-3512
sc-3512A
10 mg
100 mg
500 mg
$51.00
$231.00
$523.00
63
(1)

Etoposide stabilizes the DNA-topoisomerase II complex, affecting DNA integrity and potentially challenging RPA2 function.

Cisplatin

15663-27-1sc-200896
sc-200896A
100 mg
500 mg
$138.00
$380.00
101
(4)

By forming DNA adducts, Cisplatin can disrupt DNA replication machinery, potentially impacting RPA2 function.

Olaparib

763113-22-0sc-302017
sc-302017A
sc-302017B
250 mg
500 mg
1 g
$210.00
$305.00
$495.00
10
(1)

As a PARP inhibitor, Olaparib can cause replication stress and potentially affect RPA2 dynamics in the context of DNA repair.

Gemcitabine Hydrochloride

122111-03-9sc-204763
sc-204763A
25 mg
100 mg
$96.00
$289.00
13
(1)

As a nucleoside analog, Gemcitabine can be incorporated into DNA and cause replication blocks, potentially involving RPA2.

Fluorouracil

51-21-8sc-29060
sc-29060A
1 g
5 g
$37.00
$152.00
11
(1)

This thymidylate synthase inhibitor can cause replication stress, potentially affecting RPA2 function.

Bleomycin Sulfate

9041-93-4sc-200134
sc-200134A
sc-200134B
sc-200134C
10 mg
50 mg
100 mg
500 mg
$210.00
$624.00
$1040.00
$2913.00
38
(4)

By causing DNA breaks, Bleomycin can challenge the DNA repair machinery and potentially influence RPA2 dynamics.

L-Mimosine

500-44-7sc-201536A
sc-201536B
sc-201536
sc-201536C
25 mg
100 mg
500 mg
1 g
$36.00
$88.00
$220.00
$436.00
8
(2)

By chelating iron and inhibiting DNA replication, Mimosine might affect RPA2 function.